First reports of serious adverse drug reactions in recent weeks

  • PDF / 68,344 Bytes
  • 2 Pages / 612.28 x 790.87 pts Page_size
  • 66 Downloads / 227 Views

DOWNLOAD

REPORT


First reports of serious adverse drug reactions in recent weeks The following table contains an overview of first published case reports of serious adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage.

Reactions and the customized Reactions Pharmacovigilance Service are produced by Adis, a Wolters Kluwer business, and monitor >4000 journals, including relevant MEDLINE- and EMBASE-indexed journals, as well as companion journal supplements, major scientific meetings, the newsletters from the >80 national centres participating in the WHO International Drug Monitoring Programme, media releases, pharmaceutical company websites, and regulatory agency websites.

Drug and serious adverse reaction

Reference

Allopurinol: viral meningitis

Govani SM, Higgins PDR. Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD. J Crohn’s Colitis 2010 Oct; 4 (4): 444-9

Alteplase: interaction with irbesartan leading to orolingual angioedema in an elderly patient

Tan CH, Tang SC, Lin RJ, et al. Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker. J Neurol Neurosurg Psychiatry 2010 Oct; 81 (10): 1079

Amfetamine mixed salts: haemorrhagic stroke

Kapetanovic S, Kim MA. Hemorrhagic stroke in a patient recently started on mixed amphetamine salts. Am J Psychiatry 2010 Oct; 167 (10): 1277-8

Amitriptyline/metoprolol: drug reaction with eosinophilia and systemic symptoms syndrome?

van Westerloo DJ, Juffermans NP. Red and wet. Neth J Med 2010 May; 68 (5): 228-31

Amrubicin/nedaplatin: herpes zoster or nonsustained ventricular tachycardia

Koizumi T, Agatsuma T, Ichiyama T, et al. Salvage chemotherapy with amrubicin and platinum for relapsed thymic carcinoma: experience in six cases. Med Oncol 2010 Jun; 27 (2): 392-6

Antineoplastics: renal cell carcinoma?

Parajuli R, Altman JK, Kuzel T, et al. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association? Am J Hematol 2010 Oct; 85 (10): 829

Bortezomib: myelosuppression in an elderly patient

Libby E, Candelaria-Quintana D, Moualla H, et al. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen. Am J Hematol 2010 Sep; 85 (9): 733-4

Carisoprodol overdose: partial Parinaud’s syndrome and ocular motility disorders

O’Malley RN, O’Malley GF. Reversible partial Parinaud’s syndrome caused by carisoprodol overdose [abstract no. 201]. Clin Toxicol 2010 Jul; 48 (6): 654

Clarithromycin: interaction with hydrocodone/ valproic acid leading to fatal hydrocodone overdose in a child

Madadi P, Hildebrandt D, Gong IY, et al. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. Pediatrics 2010 Oct 126 (